EA201691147A1 - Ионные водные композиции - Google Patents

Ионные водные композиции

Info

Publication number
EA201691147A1
EA201691147A1 EA201691147A EA201691147A EA201691147A1 EA 201691147 A1 EA201691147 A1 EA 201691147A1 EA 201691147 A EA201691147 A EA 201691147A EA 201691147 A EA201691147 A EA 201691147A EA 201691147 A1 EA201691147 A1 EA 201691147A1
Authority
EA
Eurasian Patent Office
Prior art keywords
mucosa
respiratory tract
nasal
conditions associated
treating conditions
Prior art date
Application number
EA201691147A
Other languages
English (en)
Other versions
EA031541B1 (ru
Inventor
Константинос Алевизопоулос
Original Assignee
Геролиматос Интернэшнл С.А.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=52002945&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EA201691147(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Геролиматос Интернэшнл С.А. filed Critical Геролиматос Интернэшнл С.А.
Publication of EA201691147A1 publication Critical patent/EA201691147A1/ru
Publication of EA031541B1 publication Critical patent/EA031541B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/164—Amides, e.g. hydroxamic acids of a carboxylic acid with an aminoalcohol, e.g. ceramides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/748—Cyanobacteria, i.e. blue-green bacteria or blue-green algae, e.g. spirulina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/02—Algae
    • A61K36/03—Phaeophycota or phaeophyta (brown algae), e.g. Fucus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/02—Algae
    • A61K36/04—Rhodophycota or rhodophyta (red algae), e.g. Porphyra
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Botany (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Otolaryngology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

В настоящей заявке раскрыты ионные водные композиции, применимые для промывания носовых ходов для облегчения снятия отека слизистой оболочки дыхательных путей, например назальной слизистой оболочки, для лечения состояний, связанных с дыхательными путями и/или слизистой оболочкой дыхательных путей, включая, например, хронический риносинусит, синусит, аллергический ринит и назальные полипы. Композиция включает ионный водный раствор и составляющие, полученные из водорослей, такие как разветвленные сульфатированные полисахариды, имеющие средний молекулярный вес более 4 кДа и содержащие группы L-фукозы и сульфатного эфира, или экстракты из бурых водорослей. Также обсуждены способы и фармацевтические композиции для лечения состояний, связанных с дыхательными путями и/или слизистой оболочкой дыхательных путей, включая, например, хронический риносинусит.
EA201691147A 2013-12-03 2014-11-28 Ионные водные композиции EA031541B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361911071P 2013-12-03 2013-12-03
PCT/EP2014/075983 WO2015082356A1 (en) 2013-12-03 2014-11-28 Ionic aqueous compositions

Publications (2)

Publication Number Publication Date
EA201691147A1 true EA201691147A1 (ru) 2016-10-31
EA031541B1 EA031541B1 (ru) 2019-01-31

Family

ID=52002945

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201691147A EA031541B1 (ru) 2013-12-03 2014-11-28 Ионные водные композиции

Country Status (18)

Country Link
US (2) US10485819B2 (ru)
EP (1) EP3076983B2 (ru)
CN (2) CN105792835B (ru)
AU (1) AU2014359488B2 (ru)
CA (1) CA2932237C (ru)
CY (1) CY1122189T1 (ru)
DK (1) DK3076983T3 (ru)
EA (1) EA031541B1 (ru)
ES (1) ES2753218T3 (ru)
HR (1) HRP20191871T1 (ru)
HU (1) HUE045990T2 (ru)
IL (1) IL245920B (ru)
LT (1) LT3076983T (ru)
PL (1) PL3076983T3 (ru)
PT (1) PT3076983T (ru)
RS (1) RS59437B1 (ru)
SI (1) SI3076983T1 (ru)
WO (1) WO2015082356A1 (ru)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LT3076983T (lt) * 2013-12-03 2019-11-11 Gerolymatos Int S A Joninės vandeninės kompozicijos
EP2985019B1 (en) 2014-08-16 2021-10-20 Church & Dwight Co., Inc. Nasal composition having anti-viral properties
EP2985027B1 (en) 2014-08-16 2021-03-31 Church & Dwight Co., Inc. Nasal composition comprising mixture of hyaluronic acids and saline solution
BR112018016651A2 (pt) 2016-02-17 2018-12-26 Ent Tech Pty Ltd composições e métodos para tratamento de doença e distúrbios de sinusite
ITUA20164387A1 (it) * 2016-06-15 2017-12-15 Neilos S R L Composizione farmaceutica comprendente Cetraria islandica Ach., sodio ialuronato e una soluzione salina per il trattamento di affezioni dell'apparato respiratorio.
IT201600078342A1 (it) * 2016-07-26 2018-01-26 Farm S R L C U S Processo per la ristrutturazione idroionica delle acque termali e marine
FR3056911B1 (fr) * 2016-10-03 2019-07-19 Ys Lab Composition aqueuse derivee d’eau de mer et d’algues marines
KR101840758B1 (ko) 2016-10-19 2018-03-21 국립해양생물자원관 두켜부채 추출물을 유효성분으로 함유하는 비용종 질환 예방 또는 치료용 조성물
EP3415154A1 (en) * 2017-06-16 2018-12-19 Sofibel S.A.S. Nasal composition
CN107308183A (zh) * 2017-07-13 2017-11-03 深圳市新量子科技有限公司 一种辅助治疗血液病的中药或食物氢氧根负离子水剂
ES2970872T3 (es) * 2017-08-07 2024-05-31 Corbinos Pubill Maria Teresa Formulaciones equilibradoras de agua de mar y polvo de sal y composiciones nutricionales y farmacéuticas
AT16516U1 (de) * 2019-03-18 2019-11-15 Ulrich Sekotill Mba Nasenspray
FR3099051A1 (fr) * 2019-07-25 2021-01-29 Laboratoires Grimberg Composition pour pulvérisation nasale ou buccale contenant du soufre
IL297853A (en) * 2020-05-04 2023-01-01 Joseph Milstein Vsv (vitamin c-spirulina-vitamin d) composition, kit and method
EP3932411A1 (en) * 2020-06-30 2022-01-05 GSK Consumer Healthcare SARL Antiviral pharmaceutical composition
CN111743922B (zh) * 2020-07-14 2022-03-29 华熙生物科技股份有限公司 一种提高益生菌在鼻腔中的定植和活性的组合物及在鼻腔护理中的应用
RU2760825C1 (ru) * 2020-11-30 2021-11-30 Федеральное государственное бюджетное образовательное учреждение дополнительного профессионального образования «Российская медицинская академия непрерывного профессионального образования» Министерства здравоохранения Российской Федерации Способ лечения больных аллергическим ринитом в сочетании с хроническим риносинуситом бактериальной этиологии с использованием отечественного топического иммунокорректора
CN116211884B (zh) * 2023-02-16 2024-05-17 海孵(海南自贸区)医疗科技有限责任公司 一种鼻腔喷雾剂及其制备方法

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1123146A (zh) * 1994-11-18 1996-05-29 杨孟君 抗感冒药物
FR2769503B1 (fr) 1997-10-10 1999-12-17 Renee Jane Maugendre Composition a base d'eau de mer destinee au lavage des fosses nasales
FR2780285B1 (fr) * 1998-06-29 2001-10-05 Goemar Lab Sa Utilisation de solutions salines isoosmotiques, leur procede de preparation et medicaments anti-inflammatoires a base de ces solutions
JP2000229832A (ja) * 1999-02-09 2000-08-22 Shiseido Co Ltd 皮膚外用剤
DE60035604T2 (de) * 1999-08-20 2008-04-17 Takara Bio Inc., Otsu Heilmittel
JP4502152B2 (ja) * 1999-09-01 2010-07-14 株式会社鶴見製作所 電動ポンプの制御装置
JP3984402B2 (ja) * 1999-10-12 2007-10-03 株式会社マルイ物産 フコイダン様多糖複合体の製造方法及びそれを主成分とする免疫賦活剤
US20050255564A1 (en) * 2002-01-18 2005-11-17 Takara Bio Inc Sulfated fucan
CN1259863C (zh) * 2003-03-07 2006-06-21 禹东鹏 一种海藻饮品的生产方法
US20070224216A1 (en) * 2004-05-04 2007-09-27 Jane Teas Methods and Compositions Related to Antiviral Therapy Using Algae and Cyanobacteria
CN1282460C (zh) * 2004-12-10 2006-11-01 上海申任生物工程有限公司 一种治疗感冒的中药及其制备工艺
US20070135377A1 (en) * 2004-12-10 2007-06-14 Roman Stephen B Thixotropic anti-viral formulation
JP5006877B2 (ja) * 2005-06-24 2012-08-22 デザート レイク テクノロジーズ 藍藻類の精製成分および使用方法
JP2007061058A (ja) * 2005-09-02 2007-03-15 Hideo Yamamoto 糖鎖栄養素を含む免疫強化食品及びその製造方法
US7541052B1 (en) * 2005-12-23 2009-06-02 Scott Cordray Hypertonic solutions and method of treatment
JP2008063241A (ja) * 2006-09-05 2008-03-21 Riken Vitamin Co Ltd 免疫賦活剤
CN106038481A (zh) * 2007-06-28 2016-10-26 锡德克斯药物公司 皮质类固醇水溶液的鼻部和眼部给药
WO2009027057A1 (en) * 2007-08-24 2009-03-05 Marinomed Biotechnologie Gmbh Antiviral composition comprising a sulfated polysaccharide
PT2303287E (pt) * 2008-07-01 2014-02-27 Marinomed Biotechnologie Gmbh Biopolímeros antialérgicos marinhos
WO2010086746A2 (en) * 2009-01-28 2010-08-05 Life Science Nutrition As Compositions and methods of treating viral infections
JP2011073987A (ja) 2009-09-29 2011-04-14 Genki.Com 21:Kk フコイダン用いた鼻喉吸入器、のどあめ、鼻腔用保湿剤。また流動層造粒加工したフコイダン。
DE202009014631U1 (de) * 2009-10-29 2010-05-20 Jacob, Roland, Dr. Funktionelle Nasenspüllösung
US10786528B2 (en) * 2010-02-22 2020-09-29 Helen Fitton Anti-viral formulations
CN102028945B (zh) * 2011-01-06 2013-07-10 中国医学科学院医学生物学研究所 螺旋藻多糖免疫佐剂及含有该佐剂的流感疫苗
WO2012126777A1 (en) 2011-03-18 2012-09-27 Marinomed Biotechnologie Gmbh Inhibition of neuraminidase activity
US20130028882A1 (en) * 2011-07-07 2013-01-31 Humanitas Technology, LLC Antiviral compositions and methods of their use
AU2013375786B2 (en) 2013-01-25 2018-10-04 Marinova Pty Ltd Treatment methods
LT3076983T (lt) * 2013-12-03 2019-11-11 Gerolymatos Int S A Joninės vandeninės kompozicijos
US10485253B2 (en) * 2017-08-21 2019-11-26 Mustapha Benmoussa Method of microalgal biomass processing for high-value chemicals production, the resulting composition of butyrogenic algal slowly fermenting dietary fiber, and a way to improve colon health using a slowly fermenting butyrogenic algal dietary fiber

Also Published As

Publication number Publication date
EP3076983B1 (en) 2019-08-21
HUE045990T2 (hu) 2020-02-28
CA2932237A1 (en) 2015-06-11
IL245920A0 (en) 2016-07-31
CN105792835B (zh) 2022-03-25
ES2753218T3 (es) 2020-04-07
US20170000817A1 (en) 2017-01-05
CN114569549B (zh) 2024-03-15
US11672821B2 (en) 2023-06-13
CA2932237C (en) 2022-12-13
CY1122189T1 (el) 2020-11-25
US10485819B2 (en) 2019-11-26
WO2015082356A1 (en) 2015-06-11
AU2014359488B2 (en) 2020-01-23
DK3076983T3 (da) 2019-10-28
AU2014359488A1 (en) 2016-06-16
CN105792835A (zh) 2016-07-20
RS59437B1 (sr) 2019-11-29
PL3076983T3 (pl) 2020-01-31
EP3076983A1 (en) 2016-10-12
IL245920B (en) 2019-10-31
US20200061100A1 (en) 2020-02-27
LT3076983T (lt) 2019-11-11
EP3076983B2 (en) 2024-08-14
CN114569549A (zh) 2022-06-03
HRP20191871T1 (hr) 2020-01-10
SI3076983T1 (sl) 2019-12-31
PT3076983T (pt) 2019-10-31
EA031541B1 (ru) 2019-01-31

Similar Documents

Publication Publication Date Title
EA201691147A1 (ru) Ионные водные композиции
EA201800367A1 (ru) Способы лечения болезни хантингтона
EA201792354A1 (ru) Композиции обетихолевой кислоты и способы применения
EA201890641A2 (ru) СТИМУЛЯТОРЫ sGC
EA201990616A3 (ru) Дендримероподобные аминоамиды, обладающие активностью блокаторов натриевых каналов, для лечения сухости глаз и других заболеваний слизистых оболочек
MX363457B (es) Compuestos de sulfonamida heterociclica sustituida utiles como moduladores del canal del receptor de potencial transitorio a1 (trpa1).
EA201491970A1 (ru) Циклические мостиковые простые эфиры в качестве ингибиторов dgat1
CY1122500T1 (el) Φαρμακευτικη συνθεση που περιεχει παραγωγα γλουταριμιδιου, και εφαρμογη αυτης για την αγωγη ηωσινοφιλικων νοσων
BR112015001847A2 (pt) composições e tratamento para doenças e distúrbios nos olhos
NZ709803A (en) Compositions comprising 15-ohepa and methods of using the same
MX355330B (es) Formas cristalinas de compuestos terapeuticos y sus usos.
EA202091396A1 (ru) Композиции и способы лечения метаболических состояний
EA201491500A1 (ru) Способы лечения фиброза
EA201891576A1 (ru) Функционализированные пентановые кислоты для применения при инфекциях, вызванных вирусом гриппа
EA201690783A1 (ru) Вещества, фармацевтическая композиция и методы применения при лечении воспалительных заболеваний
EA202092695A1 (ru) Композиции, содержащие глюкозу и гемицеллюлозу, и их применение
EA201690854A1 (ru) Фармацевтические композиции с гидратирующим и смазывающим действием
EA201890638A1 (ru) Отклоняющие кислоты, содержащие водорастворимое замедляющее действие средство, а также способы изготовления и применения
EA201491375A1 (ru) Композиция для лечения волос
BR112017014016A2 (pt) método de redução da pressão intraocular, e, composição farmacêutica.
MY182591A (en) Compositions for use in treating eye disorders using dipyridamole
IN2013MU03773A (ru)
EA201591180A1 (ru) Составы ингибитора lfa-1
BR112013033060A2 (pt) solução oftálmica contendo ácido hialurônico ou sal deste e propileno glicol
BR112015015855A2 (pt) composições líquidas de stévia

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KG TJ TM